http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2359676-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0bc73ac3c99c60a428c6b895982df22b |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate | 2006-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2009-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa26cbb6307dd249c92e544ace1c0d18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eebdcc4ed87770f42ec9523cd87520e9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b57d90e51c27ec52463a19d51d73e64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62d154258a7c4ce64522b62970352fbc |
| publicationDate | 2009-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2359676-C2 |
| titleOfInvention | Way of correction of post-evacuation syndrome at patients with intense malignant ascites |
| abstract | FIELD: medicine. n SUBSTANCE: invention concerns medicine, namely to oncology, surgery and an intensive care and can be used as correction of a post-evacuation syndrome at patients with an intense ascites owing to a peritoneum carcinomatosis. For this purpose excision of an ascitic liquid is performed to the patient. Then the received ascitic liquid is concentrated and filtered by means of the haemodialysis filter, and then the concentrate is filtered with the help of a plasmafilter. A hypochlorite of sodium for oxidation, Cefazolinum 2.0 g/l and Prednisolonum of 90 mg/l with the subsequent reinfusion of a liquid to the patient are added to the received filtrate. n EFFECT: effective correction hypovolemic and hypoproteinetic disorders at patients with the given pathology at the expense of injection of autoascitic liquid with maximum increased concentration of protein with an invariable parity of its fractions, the lowered concentration of molecules of average mass and as much as possible remote atypical cells. n 3 tbl |
| priorityDate | 2006-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 32.